Financhill
Back

Edgewise Therapeutics, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35

EWTX
Edgewise Therapeutics, Inc.

Last Price:
$29.28
Seasonality Move:
-22.19%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is moderately bullish and EWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Edgewise Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 30.14 Sell
20-day SMA: 29.31 Sell
50-day SMA: 26.6 Buy
200-day SMA: 18.48 Buy
8-day EMA: 29.74 Sell
20-day EMA: 29.11 Buy
50-day EMA: 26.86 Buy
200-day EMA: 21.59 Buy

Edgewise Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.93 Buy
Relative Strength Index (14 RSI): 53.78 Buy
Chaikin Money Flow: 363095 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.04 - 30.2) Buy
Bollinger Bands (100): (17.54 - 27.8) Buy

Edgewise Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Edgewise Therapeutics, Inc. Stock

Is Edgewise Therapeutics, Inc. Stock a Buy?

EWTX Technical Analysis vs Fundamental Analysis

Sell
35
Edgewise Therapeutics, Inc. (EWTX) is a Sell

Is Edgewise Therapeutics, Inc. a Buy or a Sell?

Edgewise Therapeutics, Inc. Stock Info

Market Cap:
3.1B
Price in USD:
29.31
Share Volume:
627.6K

Edgewise Therapeutics, Inc. 52-Week Range

52-Week High:
31.29
52-Week Low:
10.60
Sell
35
Edgewise Therapeutics, Inc. (EWTX) is a Sell

Edgewise Therapeutics, Inc. Share Price Forecast

Is Edgewise Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Edgewise Therapeutics, Inc.

Is Edgewise Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and a decrease next year of $0.12 per share.

Technical Analysis of Edgewise Therapeutics, Inc.

Should I short Edgewise Therapeutics, Inc. stock?

* Edgewise Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.